As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Isomorphic Labs, which broke off from Google's DeepMind in 2021, raised $600 million from investors in a new funding round ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...